Seven Eight Capital, LP Arrowhead Pharmaceuticals, Inc. Transaction History

Seven Eight Capital, LP

$1.05 Billion
Q3 2024

A detailed history of Seven Eight Capital, LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 47,798 shares of ARWR stock, worth $1.01 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

47,798

Previous 34,561 38.3%

Holding current value

$1.01 Million

Previous $898,000 3.01%

% of portfolio

0.09%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$19.36 - $29.54 $256,268 - $391,020	13,237 Added 38.3%	47,798 $925,000
Q2 2024 Aug 12, 2024	SELL	$21.87 - $28.24 $889,299 - $1.15 Million	-40,663 Reduced 54.06%	34,561 $898,000
Q1 2024 May 13, 2024	BUY	$27.21 - $39.48 $1.75 Million - $2.54 Million	64,358 Added 592.29%	75,224 $2.15 Million
Q4 2023 Feb 13, 2024	SELL	$21.2 - $31.03 $288,489 - $422,256	-13,608 Reduced 55.6%	10,866 $332,000
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $308,216 - $424,445	11,764 Added 92.56%	24,474 $657,000
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $691,044 - $1.14 Million	-27,466 Reduced 68.36%	12,710 $453,000
Q1 2023 May 12, 2023	BUY	$23.68 - $38.51 $951,367 - $1.55 Million	40,176 New	40,176 $1.02 Million
Q2 2022 Aug 04, 2022	SELL	$27.79 - $50.61 $219,985 - $400,628	-7,916 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$39.62 - $69.97 $313,631 - $553,882	7,916 New	7,916 $364,000
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $480,467 - $699,220	-8,230 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$62.15 - $90.32 $422,620 - $614,176	-6,800 Reduced 45.24%	8,230 $682,000
Q4 2020 Feb 09, 2021	SELL	$43.82 - $85.37 $7,931 - $15,451	-181 Reduced 1.19%	15,030 $1.15 Million
Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $505,157 - $779,867	15,211 New	15,211 $655,000
Q2 2020 Aug 06, 2020	SELL	$26.12 - $43.27 $545,908 - $904,343	-20,900 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$20.56 - $63.12 $429,704 - $1.32 Million	20,900 New	20,900 $601,000
Q2 2019 Aug 12, 2019	SELL	$17.43 - $28.82 $412,498 - $682,054	-23,666 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$12.05 - $20.18 $285,175 - $477,579	23,666 New	23,666 $434,000
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $1.17 Million - $2.15 Million	-108,984 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$14.0 - $20.3 $1.53 Million - $2.21 Million	108,984 New	108,984 $2.09 Million

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account

Seven Eight Capital, LP Arrowhead Pharmaceuticals, Inc. Transaction History